title: Chemobrain: is it time to initiate guidelines for assessment and management?
authors.forename: Sunita K
authors.initials: SK
authors.lastname: Patel
authors.forename: Arti
authors.initials: A
authors.lastname: Hurria
authors.forename: Jeanne S
authors.initials: JS
authors.lastname: Mandelblatt
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003072:Cognition Disorders / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*